Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Deiana

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Testing and Analysis|October 31, 2012
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?Serena Deiana
Behavioural Brain Research|November 27, 2010
The cholinergic system and spatial learningSerena Deiana, Bettina Platt, Gernot Riedel
Psychopharmacology|November 14, 2008
Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmineSerena Deiana, Charles R Harrington, Claude M Wischik, et al.
Neuropharmacology|May 25, 2005
Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent ratsLiana Fattore, Sabrina Spano, Gregorio Cossu, et al.
British Journal of Pharmacology|September 2, 2004
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the ratM Sabrina Spano, Liana Fattore, Gregorio Cossu, et al.
British Journal of Pharmacology|May 5, 2018
Targeting the dopamine D<sub>1</sub> receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performanceAnton Pekcec, Niklas Schülert, Birgit Stierstorfer, et al.
Frontiers in Pharmacology|October 31, 2022
Sustained MK-801 induced deficit in a novel probabilistic reversal learning taskPatrick Latuske, Moritz von Heimendahl, Serena Deiana, et al.
Behavioural Pharmacology|August 20, 2015
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiolSerena Deiana, Akihito Watanabe, Yuki Yamasaki, et al.
Critical Reviews in Neurobiology|December 8, 2004
Cannabinoids and reward: interactions with the opioid systemLiana Fattore, Gregorio Cossu, Maria S Spano, et al.
Pharmacology, Biochemistry, and Behavior|June 7, 2005
Endocannabinoid system and opioid addiction: behavioural aspectsLiana Fattore, Serena Deiana, Sabrina M Spano, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Testing and Analysis|October 31, 2012
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?Serena Deiana
Behavioural Brain Research|November 27, 2010
The cholinergic system and spatial learningSerena Deiana, Bettina Platt, Gernot Riedel
Psychopharmacology|November 14, 2008
Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmineSerena Deiana, Charles R Harrington, Claude M Wischik, et al.
Neuropharmacology|May 25, 2005
Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent ratsLiana Fattore, Sabrina Spano, Gregorio Cossu, et al.
British Journal of Pharmacology|September 2, 2004
CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the ratM Sabrina Spano, Liana Fattore, Gregorio Cossu, et al.
British Journal of Pharmacology|May 5, 2018
Targeting the dopamine D<sub>1</sub> receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performanceAnton Pekcec, Niklas Schülert, Birgit Stierstorfer, et al.
Frontiers in Pharmacology|October 31, 2022
Sustained MK-801 induced deficit in a novel probabilistic reversal learning taskPatrick Latuske, Moritz von Heimendahl, Serena Deiana, et al.
Behavioural Pharmacology|August 20, 2015
MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiolSerena Deiana, Akihito Watanabe, Yuki Yamasaki, et al.
Critical Reviews in Neurobiology|December 8, 2004
Cannabinoids and reward: interactions with the opioid systemLiana Fattore, Gregorio Cossu, Maria S Spano, et al.
Pharmacology, Biochemistry, and Behavior|June 7, 2005
Endocannabinoid system and opioid addiction: behavioural aspectsLiana Fattore, Serena Deiana, Sabrina M Spano, et al.
Pageof 2